Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Compare which total market fund to hold in retirement in 2024 and how to balance it with other assets. Focus on cost, tax efficiency, and diversification.
28,509 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
As Dyadic gears up to report dyadic (dyai) 2025 earnings, investors should focus on revenue mix, cash runway, and par...
A notable pullback in semiconductor stocks has sharpened the buying case for a diversified chip ETF. As earnings beat...
Investors are eyeing Lilly for its resilient growth, strong pipeline, and shareholder-friendly strategy. This piece b...
As AI data centers push energy use higher, nuclear power is being framed as the only real baseload option. This piece...
AeroVironment shares extended a slide after the Space Force signaled a SCAR recompete and a stop-work order. We analy...
The US dollar still dominates oil trades, but signals of strain are rising. Tensions in the Middle East and a push to...
NVIDIA is at the center of AI-driven growth, and the latest update from CEO Jensen Huang has investors buzzing. This ...
Chipotle stock rallied today after a major bank upgraded the stock and signaling confidence in its growth plan. This ...
With rates going higher, investors seek dependable income. This story highlights four dividend stocks across core sec...
Arista Networks and AudioCodes sit at different points in the networking landscape. This article breaks down their bu...
CFO compensation rose about 8% in 2025 as long-term incentives surged last year—and long-term incentives now dominate...